Atlas Trials

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

Clinical trial NCT00764478 · COMPLETED

Trial details

NCT number
NCT00764478
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar 1 Disorder
Start date
2012-04-06
Primary completion
2014-04-30
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.